The epithelial population was marked by EPCAM gene activity whilst expression of the US FDA-approved HGSOC biomarkers MUC16 and WFDC220,21 and HGSOC-specific LAPTM4B18 confirmed tumour origin. The gene discussed is MUC16; the disease is neoplasm.